Sjöquist PO - Search Results

1

Effects of recombinant human extracellular-superoxide dismutase type C on myocardial reperfusion injury in isolated cold-arrested rat hearts.

Hatori N, Sjöquist PO, Marklund SL, Pehrsson SK, Rydén L. Hatori N, et al. Among authors: sjoquist po. Free Radic Biol Med. 1992;13(2):137-42. doi: 10.1016/0891-5849(92)90075-r. Free Radic Biol Med. 1992. PMID: 1516840 Clinical Trial.

2

Extracellular-superoxide dismutase type C (EC-SOD C) reduces myocardial damage in rats subjected to coronary occlusion and 24 hours of reperfusion.

Wahlund G, Marklund SL, Sjöquist PO. Wahlund G, et al. Among authors: sjoquist po. Free Radic Res Commun. 1992;17(1):41-7. doi: 10.3109/10715769209061087. Free Radic Res Commun. 1992. PMID: 1446846

3

Effects of recombinant human extracellular-superoxide dismutase type C on myocardial infarct size in pigs.

Hatori N, Sjöquist PO, Marklund SL, Rydén L. Hatori N, et al. Among authors: sjoquist po. Free Radic Biol Med. 1992 Sep;13(3):221-30. doi: 10.1016/0891-5849(92)90018-c. Free Radic Biol Med. 1992. PMID: 1505779

4

Endothelium bound extracellular superoxide dismutase type C reduces damage in reperfused ischaemic rat hearts.

Sjöquist PO, Marklund SL. Sjöquist PO, et al. Cardiovasc Res. 1992 Apr;26(4):347-50. doi: 10.1093/cvr/26.4.347. Cardiovasc Res. 1992. PMID: 1638565

5

Cardioprotective effects of recombinant human extracellular-superoxide dismutase type C in rat isolated heart subjected to ischemia and reperfusion.

Sjöquist PO, Carlsson L, Jonason G, Marklund SL, Abrahamsson T. Sjöquist PO, et al. J Cardiovasc Pharmacol. 1991 Apr;17(4):678-83. doi: 10.1097/00005344-199104000-00023. J Cardiovasc Pharmacol. 1991. PMID: 1711638

6

Recombinant human extracellular superoxide dismutase reduces concentration of oxygen free radicals in the reperfused rat heart.

Johansson MH, Deinum J, Marklund SL, Sjöquist PO. Johansson MH, et al. Among authors: sjoquist po. Cardiovasc Res. 1990 Jun;24(6):500-3. doi: 10.1093/cvr/24.6.500. Cardiovasc Res. 1990. PMID: 2167174

7

Beneficial effects of H290/51, a new lipid peroxidation inhibitor, on functional recovery after ischemia and reperfusion in isolated cold-arrested rat hearts.

Wang QD, Uriuda Y, Li XS, Nordlander R, Sjöquist PO, Rydén L. Wang QD, et al. Among authors: sjoquist po. J Cardiovasc Pharmacol. 1995 Jun;25(6):924-9. doi: 10.1097/00005344-199506000-00010. J Cardiovasc Pharmacol. 1995. PMID: 7564337

8

Coronary venous retroinfusion of felodipine reduces myocardial necrosis after coronary occlusion and reperfusion.

Hatori N, Haga Y, Sjöquist PO, Nordlander M, Rydén L. Hatori N, et al. Among authors: sjoquist po. J Cardiovasc Pharmacol. 1993 Jul;22(1):160-6. doi: 10.1097/00005344-199307000-00024. J Cardiovasc Pharmacol. 1993. PMID: 7690089

9

The lipid peroxidation inhibitor indenoindole H290/51 protects myocardium at risk of injury induced by ischemia-reperfusion.

Shimizu M, Wang QD, Sjöquist PO, Rydén L. Shimizu M, et al. Among authors: sjoquist po. Free Radic Biol Med. 1998 Mar 15;24(5):726-31. doi: 10.1016/s0891-5849(97)00360-2. Free Radic Biol Med. 1998. PMID: 9586802

10

Angiotensin II type 1 receptor blockade with candesartan protects the porcine myocardium from reperfusion-induced injury.

Shimizu M, Wang QD, Sjöquist PO, Rydén L. Shimizu M, et al. Among authors: sjoquist po. J Cardiovasc Pharmacol. 1998 Aug;32(2):231-8. doi: 10.1097/00005344-199808000-00010. J Cardiovasc Pharmacol. 1998. PMID: 9700985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters